1HALIAS J,DA LL M,ANDRIES A,et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding:population based case-control study [J]. BMJ. 2006;333 (7571) :726.
3ABRAHAM NS, HLATKY MA,ANTMAN EM, et, al. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines:a focused update ofthe ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents [J]. Circulation, 2010; 122(24) : 2619-2633.
4JUURLINK DN,COMES T,KO DT,et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel [J]. CMAJ,2009 ; 180:713-718.
5HSIAO FY,MULLINS CD,WEN YW,et al. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome [J]. Pharmacoepidemiol Drug Saf,2011;20 (10): 1043-1049.
6KASPRZAK M,KOZINSKI M,BIELIS L,et,al. Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome [J]. Cardiol J,2009;16 (6): 535-544.
7ELBAROUNI B,GOODMAN SG,YA NRT,et,al. Validation of the Global Registry of Acute Coronary Event (GRACE) risk seore for in-hospital mortality in patients with acute coronary syndrome in Canada [J]. Am Heart J, 2009; 158(3 ) : 392-399.
8CUISSET T, FRERE C, QUILICI J, et, al. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study [J]. J Am Coil Cardiol, 2009;54 (13) : 1149-1153.
10GARRIDO A,IBORRA MI,SAPERAS E,et al. Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors Med Clin [J]. 2010; 134(13) :577-582.
2LANAS A,SCHEIMAN J.Low-dose aspirin and upper gastrointestinal damage:epidemiology,prevention and treatment[J].Curr Med Res Opin,2007,23:163-173.
3TAN V P,YAN B P,KIERNAN T J,et al.Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention[J].Cardiovasc Revasc Med,2009,10:36-44.
4CRYER B.Management of patients with high gastrointestinal risk on antiplatelet therapy[J].Gastroenterol Clin North Am,2009,38:289-303.
5SMITH S C Jr, FRDMAN T E, HIRSHFELD J W Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention[J]. J Circulation. 2006,113:266 - 286.
